We confirmed the predominant expression of CB2R in B cells using a previously published single-cell RNA sequencing dataset (Figure 1D) and by performing RNAscope for CD19 and CNR2 on human melanoma tissues (Figure 1E). The gene discussed is CD19; the disease is melanoma.